CONMED (CNMD) Competitors $45.91 -0.56 (-1.21%) Closing price 10/7/2025 03:59 PM EasternExtended Trading$45.90 -0.01 (-0.02%) As of 10/7/2025 07:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNMD vs. MMSI, IRTC, BLCO, GKOS, TMDX, NVST, SLNO, LIVN, WRBY, and EYEShould you be buying CONMED stock or one of its competitors? The main competitors of CONMED include Merit Medical Systems (MMSI), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Envista (NVST), Soleno Therapeutics (SLNO), LivaNova (LIVN), Warby Parker (WRBY), and National Vision (EYE). CONMED vs. Its Competitors Merit Medical Systems iRhythm Technologies Bausch + Lomb Glaukos TransMedics Group Envista Soleno Therapeutics LivaNova Warby Parker National Vision Merit Medical Systems (NASDAQ:MMSI) and CONMED (NYSE:CNMD) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, media sentiment, valuation, earnings, analyst recommendations, profitability and dividends. Which has preferable valuation and earnings, MMSI or CNMD? CONMED has lower revenue, but higher earnings than Merit Medical Systems. CONMED is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMerit Medical Systems$1.36B3.61$120.36M$1.9741.98CONMED$1.31B1.09$132.42M$3.5313.01 Do insiders and institutionals hold more shares of MMSI or CNMD? 99.7% of Merit Medical Systems shares are owned by institutional investors. 3.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 3.1% of CONMED shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer MMSI or CNMD? In the previous week, Merit Medical Systems had 6 more articles in the media than CONMED. MarketBeat recorded 11 mentions for Merit Medical Systems and 5 mentions for CONMED. Merit Medical Systems' average media sentiment score of 0.90 beat CONMED's score of 0.75 indicating that Merit Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive CONMED 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate MMSI or CNMD? Merit Medical Systems currently has a consensus price target of $107.50, suggesting a potential upside of 29.99%. CONMED has a consensus price target of $59.80, suggesting a potential upside of 30.26%. Given CONMED's higher possible upside, analysts clearly believe CONMED is more favorable than Merit Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Merit Medical Systems 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89CONMED 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has more risk & volatility, MMSI or CNMD? Merit Medical Systems has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500. Comparatively, CONMED has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Is MMSI or CNMD more profitable? Merit Medical Systems' return on equity of 15.07% beat CONMED's return on equity.Company Net Margins Return on Equity Return on Assets Merit Medical Systems8.31% 15.07% 8.60% CONMED 8.31%14.43%6.05% SummaryMerit Medical Systems beats CONMED on 11 of the 15 factors compared between the two stocks. Get CONMED News Delivered to You Automatically Sign up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNMD vs. The Competition Export to ExcelMetricCONMEDMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$1.44B$17.56B$6.11B$22.14BDividend Yield1.72%1.66%5.70%3.57%P/E Ratio13.0116.7885.5429.64Price / Sales1.092.28623.7495.37Price / Cash6.9213.0637.7824.65Price / Book1.473.0713.114.61Net Income$132.42M$472.95M$3.30B$1.01B7 Day Performance-2.67%0.75%3.93%-0.14%1 Month Performance-14.63%-7.49%8.39%2.28%1 Year Performance-28.15%-11.25%87.02%14.59% CONMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNMDCONMED4.6307 of 5 stars$45.91-1.2%$59.80+30.3%-28.3%$1.44B$1.31B13.013,900MMSIMerit Medical Systems4.6852 of 5 stars$83.31-1.1%$107.50+29.0%-12.7%$4.99B$1.36B42.297,400Analyst ForecastIRTCiRhythm Technologies1.147 of 5 stars$175.74+0.1%$172.17-2.0%+194.3%$5.64B$591.84M-59.982,000Analyst ForecastBLCOBausch + Lomb1.9927 of 5 stars$14.87-2.2%$15.60+4.9%-22.0%$5.38B$4.79B-19.0613,500News CoverageAnalyst ForecastGKOSGlaukos4.4736 of 5 stars$86.64-0.9%$122.00+40.8%-33.3%$5.01B$383.48M-52.51780Analyst ForecastTMDXTransMedics Group3.256 of 5 stars$113.93-1.5%$125.40+10.1%-14.1%$3.94B$441.54M59.03210NVSTEnvista3.7378 of 5 stars$20.64-1.0%$20.92+1.4%+11.8%$3.46B$2.51B64.5012,300SLNOSoleno Therapeutics4.4049 of 5 stars$58.45-1.3%$115.09+96.9%+30.4%$3.15B$32.66M-14.1230Analyst ForecastLIVNLivaNova2.5043 of 5 stars$52.63-1.4%$59.71+13.5%-1.0%$2.91B$1.25B-13.532,900WRBYWarby Parker1.7361 of 5 stars$25.41-3.1%$24.75-2.6%+50.6%$2.76B$771.32M-362.953,780Positive NewsAnalyst ForecastEYENational Vision2.3071 of 5 stars$28.15-2.5%$24.73-12.2%+169.4%$2.29B$1.82B-156.3913,411Positive News Related Companies and Tools Related Companies MMSI Competitors IRTC Competitors BLCO Competitors GKOS Competitors TMDX Competitors NVST Competitors SLNO Competitors LIVN Competitors WRBY Competitors EYE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNMD) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredU.S. Government Blocked NVIDIA’s Buyout… Here’s WhyThe U.S. government doesn't normally block billion-dollar tech deals. But when NVIDIA tried to acquire this...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredU.S. Government Sparking Crypto RallySecond Chances Don't Come Often in Crypto My "Crypto Bull Run Millionaire Blueprint" reveals everything - w...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CONMED Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CONMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
